Curriculum Vitae för Parkinsonfondens Styrelse

Transkript

1 Curriculum Vitae för Parkinsonfondens Styrelse Curriculum vitae for Susanna Lindvall Born: Oradea, Romania, November 20, 1948 Citizenship: Swedish Home address: Kastrupgatan 10, 4 tr SE Kista Sweden Work address: ParkinsonFonden Skeppargatan 52 nb Stockholm Sweden VASCAIA AB Arenavägen 41, plan 12 SE Stockholm Sweden Phone: (8) susanna.lindvall@swipnet.se Education 1972 B.Sc Organic chemistry, Stockholm University 2002 NLP Practitioner Research and professional experience: Stockholm University, Research regarding cytochrome-c peroxidase The Nat Food Administration, Research regarding chlor-organic pesticides Arla R&D, Research regarding Functional foods Arla R&D Chemistry and microbiology research Arla R&D Education and Information Arla Foods Information specialist Committees President of the Swedish Parkinson s Disease Association Member of the Nordic Parkinson Federation (NPR) Member of the Arvid Carlsson Foundation present President of the Swedish Parkinson Foundation

2 present Vice president of the European Parkinson s Disease Association (EPDA) Member of the Embryonic Stem Cell Research Oversight (ESCRO) at Karolinska Institutet 2007 present Member of the Swedish Parkinson Academy steering group Projects EPDA Awareness Campaign REPLACES (Restorative plasticity at corticostriatal excitatory synapses), 7th FWP Editorial Boards 1996-present Parkinson Journalen present European Neurological Journal 2009-present European Neurological Review Awards and honors Received The Swedish Parkinson s Disease Association Honorary medal 2001 The Swedish Parkinson s Disease Association s Susanna Lindvall Prize Publications 1. Book: Parkinsons sjukdom Behandling-Omvårdnad-Tips, Ny undersökning av patienter med dosglapp vid Parkinsons sjukdom, Ö. Skogar, S. Lindvall, M. Carlsson, Medicinsk Access, Wearing-off is a common concern for patients with Parkinson s disease, Ö. Skogar, S. Lindvall, M. Carlsson, Poster at MDS Congress, Kyoto, Patientenkät i Medlemsinfo genomförd av ParkinsonFörbundet, S.Lindvall, PJ Parkinson från diagnos till reparation, S. Lindvall, Medicinsk Access, Restles Leg Syndrome (RLS ) och Parkinson, S.Lindvall, Incitament, EPDA:s Awareness projekt gör många medvetna! S.Lindvall, Medicinsk Access, 6, Nyhet från American Academy of Neurology (AAN) kongressen i Chicago, S. Lindvall, PJ, Den äldre parkinsonpatienten. Utredning, diagnostik och åtgärder för individuellt omhändertagande, Svensk geriatrisk förening; Anhörigas situation.s.lindvall, J.Lökk, Redressing the Balance in Parkinson s Disease Management with a Greater Focus on Non-motor Symptoms and Care-giver Health, European Neurological Review, Rätt vård får inte vara ett postkodlotteri, S.Lindvall, K-G Skoog, Debate article,dagens Samhälle, European Neurological Review Volume 4, 2010, Foreword 13. Parkinsonsjuka offras när landstingen sparer, Debate article, Dagens Nyheter, 2 September A Qualitative Assessment of the Educational and Support Needs of People Living with Parkinson s Disease, Poster at World Parkinson Congress, Glasgow, Awareness of the need for more focused research into Parkinson s disease, Poster at World Parkinson Congress, Glasgow, Life with Parkinson s - Awareness Campaign, Poster at World Parkinson Congress, Glasgow, Forska och Vårda Debate article, Medicinsk Access nr 7, Parkinsonskolor skapar rättvisa förutsättningar över hela landet Debate article, Medicinsk Access Nr 8/9, Impulse control disorder/behaviour related to prolonged release oral and transdermal dopamine agonists: a comparative survey across European centres (Poster at The 8th International Congress on Mental Dysfunction & Other Non-Motor Features in Parkinson's Disease & Related Disorders, MDPD 2012, Berlin) 20. Prolonged release dopamine agonists in clinical practice: a comparative European multicentre survey of tolerability rates and impulse control behaviour trends in young and old PD ( Poster at MDS 2012, Dublin)

3 21. Early morning off periods in Parkinson's disease: Characterisation of non motor patterns and treatment effect. An international study. ( Poster at MDS 2012, Dublin) 22. Book: co author in Parkinson s Disease Role of continuous dopaminergic stimulation, Chapter 4, Book: co author in I MIG ( In me ) The Treasure Factory, Early morning off periods in Parkinson's disease: Range and non motor patterns from an international study ( Poster at MDPD, 2013, Seoul) Susanna Lindvall (Sweden) was elected as Vice President of the European Parkinson's Disease Association (EPDA) at the General Assembly on October 10, 2005 in Dublin, Ireland. She was born in Romania and has lived in Sweden since 1962 where she graduated as a B.Sc in organic chemistry at the University of Stockholm. She was working as an information specialist at a dairy company, Arla Foods until 2010, when she retired. From she was President of the Swedish Parkinson's Disease Association and since 2002 she has been a vice president of the association and now co-opted member of the board. She has been board member of the Arvid Carlson Foundation 2001 to She is the President of the Swedish Parkinson Foundation since Curriculum Vitae Prof. Per Lars Anders ODIN Auf dem Hohen Ufer 65b D Bremen Mobile +49(0) per.odin@med.lu.se Nationality: Swedish Born: 10 th. July, 1957 in Uppsala Family: Married to Katja Odin, 3 children. Education: 9 years of compulsory school, Örjansskolan, Halmstad years of college, Natural Science Program, Halmstad Medical studies, University of Uppsala Medicine Kandidat Degree, University of Uppsala Läkarexamen Degree, University of Uppsala PhD research, Dept. of Medical and Physiological Chemistry, Uppsala Univ (Tutor: Professor Björn Öbrink). Doctor of Medical Sciences, University of Uppsala Thesis: Chemical, immunochemical and immunohistochemical characterization of the cell adhesion molecule CellCAM 105 Employment/Exams (employment details separately below): Clinical duties and research Department of Neurology, Lund University (Research area: Neurotransplantation, Neuroprotection) (Heads of Department: Prof. Olle Lindvall and Prof. Anders Björklund) Certified physician ( legitimerad läkare ), University Hospital, Lund Neurology Specialist, University Hospital, Lund Associate Professor ( Docent ) of Neurology, Lund University

4 Specialist, Consultant ( Bitr. Överläkare ), Dept. of Neurology, Lund Lecturer ( Universitetslektor (50%)), Lund University Consultant ( Oberarzt ), Dept. of Neurology, The Hannover Medical School (Head of Department: Prof. Reinhard Dengler) Associate Professor ( Dr. med. habil. ), The Hannover Medical School Extraordinary Professor, ( Außerplanmäßiger Professor ), The Hannover Medical School National Coordinator of Kompetenznetz-Parkinson and Consultant at the Dept. of Neurology, Philipps-University, Marburg (Head of Department: Prof. Wolfgang Oertel) Head of the Dept. of Neurology, Central Hospital, Bremerhaven Professor Department of Neurology, Lund University Scientific publications: 143 (including 75 original publications and 67 bookchapters/reviews) H-index: 29 Average Citations per item: Scientific lectures and posters: >200 Clinical positions University Hospital, Lund Internship ( AT-läkare ) University Hospital, Lund Resident physician ( FV-läkare ) University Hospital, Lund Specialist ( avdelningsläkare )/ Dept. of Neurology Consultant ( bitr. överläkare ) The Hannover Medical School Consultant ( Oberassistent ) Dept. of Neurology Philipps-University Marburg Consultant, Coordinator of Dept. of Neurology Kompetenznetz-Parkinson Central Hospital, Bremerhaven Head of Dept Dept. of Neurology Research positions University of Uppsala PhD-Student Doktorand Dept. of Med. and Physiol. PhD-Student Doktorand (Tutor) Chemistry PhD-Student Doktorand (MFR*) PhD-Student Doktorand Lund University Post-doc. Forskarassistent (MFR*) Dept. of Neurology Post-doc. Forskarassistent Post-doc. Forskarassistent (MFR*) Post-doc. Forskarassistent Post-doc. Forskarassistent

5 Post-doc. Forskarassistent (MFR*) Post-doc. Forskarassistent Post-doc. Forskarassistent Post-doc. Forskarassistent Post-doc. Forskarassistent Post-doc. Forskarassistent Post-doc. Forskarassistent Post-doc. Forskarassistent Lund University Senior research fellow Dept. of Neurology ( Universitetslektor ) Lund University Professor Dept. of Neurology ( Adj. Professor ) Lund University Professor of Clinical Neuroscience Dept. of Neurology Tutor for doctoral students, thesis finished*: N. Schimke, 2003 A. Brederlau, 2003 A. van den Hoogen, 2005 H. Honig, 2011 T. Fox, 2013 *A German medical dissertation is normally based on about one year of full-time research and is usually equivalent to one scientific publication. Leading posts in academic organizations Chairman, Scientific Committee, Swedish National Guidelines for PD (Socialstyrelsen), Chairman, Swedish Movement Disorder Society, SWEMODIS, Chairman, Scandinavian Movement Disorder Society, ScandMODIS, Chairman, SWEPAR (Swedish Parkinson Research Network), Member of the executive committee of Movement Disorder Society, European Section, Member of the CSPC (Congress Scientific Program Committee) of MDS, Member of the board (treasurer) of Competence Network Parkinsons disease, CNP, Clinical trials I have been actively involved as principal investigator in the clinical studies listed below, was national co-ordinating investigator for the high-dose cabergoline study and leading German investigator (LKP) for the nasal apomorphine study (20102D05): Apomorphin Inj. Lund University Sponsor: Novo Nordisk Riluzol The Hannover Medical School Phase III Sponsor: Aventis

6 High dose Cabergolin University of Marburg Phase III Sponsor: Pharmacia E Central hospital, Bremerhaven Phase IIb Sponsor: Eisai/i3 E Central hospital, Bremerhaven Phase IIb Sponsor: Eisai/i3 PDT 301, DAT-Scan in PD Central hospital, Bremerhaven Phase III Dementia Sponsor: GE Health SP790/791, Rotigotine in RLS Central hospital, Bremerhaven Phase III Sponsor: Schwarz Pharma E2007-E Central hospital, Bremerhaven Phase III Sponsor: Eisai/Quintiles 20102D05 Apomorphine Central hospital, Bremerhaven Phase III Nasal Sponsor: MDS/Britannia E2007-G Central hospital, Bremerhaven Phase III 2007 Sponsor: Eisai/Quintiles Pramipexole in Central hospital, Bremerhaven Phase III 2007 Parkinson+Depression Sponsor: Boehringer-Ingelheim Pramipexole ER Central hospital, Bremerhaven Phase III 2007 Sponsor: Boehringer-Ingelheim S Rubens Study Central hospital, Bremerhaven Phase III 2008 Sponsor: Solvay Pharma SP882 Neupro perioperativ Central hospital, Bremerhaven Phase III 2008 Sponsor: Schwarz Pharma S Duodopa Central hospital, Bremerhaven Phase III Sponsor: Solvay Pharma S Duodopa Central hospital, Bremerhaven Phase III Sponsor: Solvay Pharma VR040/2/008 Apomorphine Central hospital, Bremerhaven Phase III 2008 Inhalation Sponsor: Vectura

7 S Duodopa Central hospital, Bremerhaven Phase I 2010 Sponsor: Solvay Pharma PYM50028 Cogane Central hospital, Bremerhaven Phase II 2011 Sponsor: Phytopharm PO4938 Predeladent Central hospital, Bremerhaven Phase III 2011 Sponsor: Schering PO5664 Predeladent Central hospital, Bremerhaven Phase III 2011 Sponsor: Schering NIC-PD Central Hospital, Bremerhaven Phase III 2012 Sponsor: German Parkinson Study Group Toledo Apomorphine Central Hospital, Bremerhaven Phase III 2014 Sponsor: Stada snn PDGF Central Hospital, Bremerhaven Phase II 2014 Sponsor: EU, Newron KW-6002 Istradefylline Central Hospital Bremerhaven Phase III 2014 Sponsor: Kyowa 10 best original publications: Pietz K., Odin P., Funa K. and Lindvall O. (1996) Protective Effect of Platelet-Derived Growth Factor protects against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture. Neurosci Lett, 204, Wenning G.K., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Brown R., Gustavii B., Hagell, P., Jahanshahi M., Sawle G., Björklund A., Brooks J.D., Marsden C.D., Quinn N.P. and Lindvall O. (1997) Short- and Long-term Survival and Function of Unilateral Intrastriatal Dopaminergic Grafts in Parkinson s Disease. Ann Neurol, 42, Pietz K., Hagell P. and Odin P. (1998) Subcutaneous apomorphine in late stage Parkinson s disease: a long term follow up. J Neurol Neurosurg Psychiatry, 65, Odin P., Oehlwein C., Storch A., Polzer U., Werner G., Renner R., Shing M., Ludolph A., Schüler P. (2006) Efficacy and safety of high-dose cabergoline in Parkinson s disease. Acta Neurol Scand, 113, Eggert K., Schrader C., Hahn M., Stamelou M., Rüssmann A., Dengler R., Oertel W., Odin P. (2008) Continuous jejunal levodopa infusion in patients with advanced Parkinson s disease: Practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol, 31, Brüggemann N., Odin P., Grünewald A., Tadic V., Hagenah J., Seidel G., Lohmann K., Klein C., Djarmati A. (2008) Alpha-synuclein duplication is present in sporadic Parkinson disease. Neurology, 71, Honig H., Antonini A., Martinez-Martin P., Forgacs I., Faye G.C., Fox T., Fox K., Mancini F., Caneci M., Odin P., Chaudhuri K.R. (2008) Intrajejunal levodopa infusion in advanced Parkinson s disease: a pilot multicentre study of effects on non-motor symptoms and quality of life. Mov Disord, 24, Antonini A., Odin P., Opiano L., Tomantscheger V., Pacchetti C., Pickut B., Gasser U.E., Calandrella D, Mancini F., Zibetti M., Minafra B., Bertaina I., De Deyn P., Cras C., Wolf E., Spielberger S., Poewe W. (2013) Effect and safety of duodenal infusion in advanced

8 Parkinson s disease: a retrospective multicenter outcome assessment in patient routine care. J. Neurol. Transm. 120, Nyholm D., Odin P., Johansson A., Chatamra K, Locke C., Freeman S., Dutta S., Othman A.A. (2013) Stable Levodopa Plasma Levels with Jejunal Infusion of Levodopa- Carbidopa Intestinal Gel in Advanced Parkinson s Disease Patients. AAPS J. 15: Olanow C.W., Kieburtz K., Odin P., Espay A.J., Standaert D.G., Fernandez H.H., Vanagunas A., Othman A.A., Widnell K.L., Robieson W.Z., Pritchett Y., Chatamra K., Benesh J., Lenz R.A., Antonini A.; LCIG Horizon Study Group. (2014) Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13, Bremerhaven 13. Aug 2014 Per Odin CV Filip Bergquist Utbildning: Läkarexamen Göteborgs Universitet 1997 Medicine doktor, farmakologi 2002 Docent i experimentell neurologi 2012 Specialistläkare neurologi 2013 Tjänster: Doktorand , Göteborgs Universitet ST-läkare neurologi, Sahlgrenska Universitetssjukhuset Postdoctoral fellow, University of Edinburgh, Scotland % Forskarassistent-tjänst (vetenskapsrådet) placerad på avd för farmakologi, Sahlgrenska akademien. Specialistläkare i neurologi, Sahlgrenska Universitetssjukhuset Aktuella uppdrag Läkemedelsansvarig läkare för neurosjukvården Ledamot av läkarprogramkommittéen Sahlgrenska Styrelseledamot SWEPAR-net Sekreterare SWEMODIS

9 Styrelseledamot Svenska Parkinsonfonden Uppdrag som rådgivare , advisory board Brittania Ltd 2014 steering committee, Global Kinetics CURRICULUM VITAE OSKAR HANSSON Associate Professor Oskar Hansson ( ), MD, PhD Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University Memory Clinic, Malmö, Skåne University Hospital, Malmö Phone: +46 (0) ; Résumé My overriding aim is to combine clinical work with innovative research to help patients suffering from neurodegenerative disorders, mainly Alzheimer s and Parkinson s diseases. I prioritize research that may have beneficial effects for patients within a relatively short period of time. My research is innovative and is the result of the combination of very wellcharacterized patient material with state-of-the-art biomedical techniques and the latest technological advances in brain imaging. My initial findings describing the use of cerebrospinal fluid biomarkers (tau and β-amyloid) for prediction of AD in patients with mild cognitive impairment have been groundbreaking and were published in 2006 (The Lancet Neurology; cited > 720 times). Since 2007, I have funded all of my research through significant independent grants from e.g. the European Research Council (ERC; Staring Grant) and the Swedish Research Council. The grants have enabled me to establish my independent line of research at the Clinical Memory Research Unit (Lund University). My work is widely recognized (cited 4800, H-index 32; Scopus) and I have participated in multi-centre studies with some of the most renowned researchers in the field (e.g. in JAMA). Our work on biomarkers has led to over 110 original articles and has already influenced the newly proposed diagnostic criteria for Alzheimer s disease and formed the scientific basis for the European Medicines Agencies (EMA) recommendation (in 2011) to use CSF biomarkers for early detection of Alzheimer s disease in clinical trials. One of our biomarker papers (Buchhave, et al 2012) has been considered one of the most important findings in Alzheimer research in 2012 (Weiner. Nat Rev Neurol. 2013; 9: 65) and one of articles published in 2013 was selected as the best article of the year in Journal of Alzheimer s disease. I am part of and I am in leading positions in several distinguished scientific networks, including a Linnaeus environment (Bagadilico, LU), Swedish Parkinson Academy (SUS), the strategic network in neuroscience at LU (MultiPark), and Swedish Brain Power (national network). 1. Higher education degree University Medical Degree (Medical Doctor) Lund Graduate School of Biomedical Research 2. Doctoral Degree Neurobiology. Neuronal cell death and restoration in the basal ganglia: implications for Huntington s and Parkinson s diseases. Supervisor: Professor Patrik Brundin (Lund University).

10 3. Post doctoral positions : Independent research at Clinical Memory Research Unit, Lund University : Independent research at Department of Neurology, Skåne University Hospital. 4. Qualification as Associate Professor (Docent level) Subject: Neuroscience. 5. Specialist certification 2012 Specialist in Neurology Senior resident (överläkare) in Neurology. 6. Recent positions to today: Senior lecturer and neurologist ( kombinationstjänst lektor/överläkare ) at both Lund University and Skåne University Hospital : Senior neurologist (överläkare) in Neurology (25%), Memory Clinic, Skåne University Hospital : Senior researcher at Lund University (75%). I have a six-year senior research position funded by the Swedish Research Council until : Assistant coordinator of Multipark; the strategic research area of Neuroscience at Lund University ( 7. Previous positions Resident in Neurology, Department of Neurology, Malmö, Skåne University Hospital Clinical internship (AT), Skåne University Hospital Junior physician, Neuropsychiatric clinic, Malmö, Skåne University Hospital Graduate student, Wallenberg Neuroscience Center, Lund University. 8a. People awarded doctorates, for which the applicant is/has been main supervisor: Peder Buchhave, dissertation 1 April I am currently main supervisor for: 1) Joakim Hertze (planned dissertation in Dec 2014); 2) Sara Hall (planned dissertation 2015); 3) Yulia Surova (planned dissertation 2016); 4) Beata Lindholm (planned dissertation 2016); 5) Anna-Märtha Gustavsson (planned dissertation 2016); 6) Maurits Johansson (planned dissertation 2018). 8b. People awarded doctorates, for which the applicant is/has been cosupervisor: 1) Sebastian Palmqvist, dissertation 6 June 2011; 2) Erik Stomrud, dissertation 12 December 2009; 3) Fredrik Boström, dissertation 12 September 2009; 4) Åsa Wallin, dissertation 12 May ) Fredrik Åhlander (planned dissertation 2017). 6) Eva Bergström Mandl (planned dissertation 2017). 7) Daniel Svärd (planned dissertation 2018).

11 8c. Postdoctoral researchers who is/has been supervised by the applicant 1) Shorena Janelidze (2013-today); 2) Olof Lindberg (2013-today) 3) Ruben Smith (2013-today) 4) Daniel Lindqvist (2011-today); 5) Sebastian Palmqvist (2011-today); 6) Edina Silajdzic (2011-today); 7) Erik Stomrud (2011-today); 8) Fredrik Boström ( ). 9. Special grounds for deduction of time after awarded doctoral degree : Resident in Neurology 50-70%, Skåne University Hospital. 2008: Four months of parental leave Clinical internship (AT) 100%, Skåne University Hospital Medical school (semester 6-11). 10a) Other research related assignments 2014 Interviewed by the national newspapers Expressen and Sydsvenska dagbladet, regarding our article in JAMA Neurology Awarded with Inga Sandeborgs research award from the Swedish Society of Medicine Interviewed by Sveriges Radio (Ekot) regarding my research findings Lion club (Skåne) research award Interviewed by the national newspaper Sydsvenska dagbladet, regarding our article on neuroinflammation and depression in Parkinson s I have received grant from the European Research Council (starting grant; Euro) Interviewed by several national and international journalists, including Sveriges Radio (Ekot). CNN published our press release, regarding our article in Archives of General Psychiatry Awarded a research position (100%) for 6 years by the Swedish Research Council today: Associate editor of Journal of Alzheimer s Disease today: Ad hoc reviewer for 20 scientific journals, including Lancet Neurology, JAMA Psychiatry and Brain. 10b) Leadership 2011-today: Elected member of the board and WP leader in the clinical part of the Linnaeus environment BAGADILICO ( at Lund University, today: Included in the steering committee of Swedish Parkinson Academy ( today: Elected member of the board of the Swedish Parkinson foundation ( 2011: Elected assistant coordinator of MultiPark ( a translational program that ranges from pre-clinical research to studies on the life situation of patients with Parkinson's disease; budget 110 billion SEK over 5 years). 10c) Research funding During the last five year I have received about million SEK in funding for my research including grants from the European Research Council (ERC Staring Grant), the Swedish research Council and The regional agreement on medical training and clinical research (ALF) between Skåne County Council and Lund University.

12 11) Publications Oskar Hansson is author of 117 peer-reviewed original articles, published between 1998 and These articles have been cited more than 4800 times (h-index: 32) according to Scopus. When analyzed with Google Scholar the articles have been cited more than 6400 times (h-index: 38) CARL KJELLGREN CURRICULUM VITAE Född 1956 UTBILDNING Statens scenskola (nuvarande Teaterhögskolan) (Treårig skådespelarutbildning, lektioner för bl a Professor Franticek Veres o Doreen Cannon,RADA o Drama Centre, London) ARBETE, Skådespelare! Malmö Stadsteater (Bl a Hippolytos i urpremiär på P O Enqvists Till Fedra ) Stockholms stadsteater (Ett stort antal ledande roller i såväl klassisk som samtida dramatik, bl a Romeo i Shakespeares Romeo o Juliet, tillhörde den fasta ensembeln till 2005, då jag sade upp min tjänst på egen begäran) Frilans, bl a huvudroll i Det värdefulla, Teateri Anställd vid Teateralliansen Medverkat i ett trettiotal svenska film- och tvproduktioner, huvudroller i bl a Black Jack (SF 1990) o Pappas flicka (SVT 1997 o 1998) ARBETE, Regissör Regisserat 8 iscensättningar på Stockholm stadsteater, bl a Arthur Millers Utsikt från en bro, Stora scenen 2001, senast August Strindbergs Paria 2012 Regiuppdrag vid: Göteborgs Stadsteater ( Ungt blod av Peter Asmussen) Malmö Stadsteater ( Rut och Ragnar av Kristina Lugn) Uppsala Stadsteater ( Oleanna av David Mamet, Som ni vill ha det av William Shakespeare) Helsingborgs Stadsteater ( Cafe Europa av R Furnescu) Riksteatern ( Häxjakten av Arthur Miller) Länsteatern Örebro ( Ett drömspel av August Strindberg) Länsteatern Växjö ( Hjälten på den gröna ön av John M Synge) Västerbottensteatern Skellefteå ( Stenar i fickan av Marie Jones) Dalateatern Falun ( Hemsöborna av August Strindberg) Teaterhögskolan Göteborg ( Partytime av Harold Pinter) Vadstenaakademin ( Will,nyskriven opera av B Tommy Andersson o Håkan Lindqvist) The Market Theatre, Johannesburg, RSA ( Dance of death av August Strindberg) RoofTop Theatre, Harare, Zimbabwe ( Superpatriots and morons ) av Daves Gusha Radioteatern, Stockholm ( Kain och Abel av Erik Åkermark, Erlanderkänslan av Björn Runeborg) ARBETE, Pedagog Återkommande lärare i scenframställning, Teater och Operahögskolan, Göteborg

13 Lärare i scenframställning, Teaterhögskolan, Stockholm 2000 Ledamot av intagningsjuryn, Teaterhögskolan, Stockholm 1999 o 2000 Ledare för svenska workshopen vid den internationella scenskolefestivalen i Sydney, Australien 1992 Masterclass, Teaterakademin Jekaterinenburg, Ryssland 1995 Masterclass, The Lab, Johannesburg, RSA 1998 Masterclass, HIFA (Harare International Festival of Arts) Harare, Zimbabwe 2009 Medlem av Svenska Teaterförbundet och Svensk Regissörsförening CV Ronny Olausson Född: 1934 i Ljungby UTBILDNING Tog studenten 1970 Tog delar av civ ing examen 1992 i Växjö IHM 1971 Företagsekonomi, 20p, KTH på 1980-talet ARBETEN Typograf Redovisningschef, Strålfors, Tf. Ekonomichef, Strålfors, VVD Smålands Invest AB, Ekonomichef, Bostads AB Poesidon, Götebog, Konsultchef, Ernst & Young, VD, Bostads AB ( FURBO), VD, Haninge Bostäder AB, Konsult inom fastighetsekonomi, Berit Scott, född 1950 FD, docent i klinisk psykologi, leg. psyk. Senior lecturer at Department of Psychology, Uppsala University L Melin, P Lindberg, B Scott - Scandinavian, informahealthcare.com A short scale for self-assessment of experiences of hearing impairment-the Hearing Coping Assessment (HCA) was developed and administered to 114 consecutive hearing-impaired patients at a Swedish hearing centre. The scale was evaluated in terms of descriptive... B Scott, L Melin - Scandinavian Journal of Psychology, Wiley Online Library Within the behavioral field, self-report inventories measuring emotional condition from a state/trait perspective are in frequent use. Some of these measures have insufficient standardisation and/or are out of date. In order to upgrade some of the frequently used self... G Andersson, L Melin, B Scott - Scandinavian, informahealthcare.com Effects of behavioural counselling of subjects with an acquired hearing loss were evaluated

14 in an experimental design. The study included a group of 20 hearing-impaired subjects who were assessed and randomly allocated to a treatment or control group. Behavioural... G Andersson, L Melin, B Scott - British journal of, informahealthcare.com Twenty elderly hearing impaired patients participated in a two-year follow-up study on the effects of behavioural treatment aimed at increasing coping with hearing impairment. Subjects who had received treatment were compared with untreated controls using the... L Melin, P Lindberg, B Scott - International Journal of, informahealthcare.com Sixty-eight elderly hearing impaired subjects were interviewed and completed self-report measures on hearing disability, dispositional optimism, dysphoria, and general health. The measures used were the Hearing Coping Assessment (HCA), the Hearing Questions (HQ)... L Lyttkens, P Lindberg, B Scott - Scandinavian, informahealthcare.com Transeataneous electrical stimulation was used in 5 consecutive patients suffering from troublesome tinnitus. The study included three parts. Part one constituted an open trial using the stimulation equipment. During this part, 2 patierts reported a reduced subjective... B Scott, P Lindberg, L Melin - International Journal of, informahealthcare.com Forty hearing-impaired subjects were exposed to three stressful communication situations in a laboratory setting. The communication patterns used and the extent to which the subjects succeeded in coping with the situations were studied. Measures, such as the life... G Andersson, L Melin, P Lindberg, B Scott - International journal of, Springer Abstract Little is known about the coping behaviors associated with hearing impairment. In this study, 24 elderly hearing-impaired participants participated in a structured video interview including communication faults (provocations) presented in association with... P Lindberg, B Scott, G Andersson - British journal of, informahealthcare.com In an experimental study involving 20 subjects functional consequences of hearing disability were assessed and counselled in accordance with behavioural principles. The aims were to develop psychological methods for analysing and relieving hearing problems. The results... B Scott, P Lindberg diva-portal.org... in DiVA. Create reference». Author: Scott, Berit. Lindberg, Per (Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Public Health and Caring Sciences) (Caring Sciences). Title: Epidemiologie... Scott, B., Nyholm, D. (2010). Patient-Perceived Retrospective Outcome of Duodenal Levodopa Infusion in Advanced Parkinson s Disease. European Neurological Journal, 2: 1-8 [More information] Johansson, A., Engler, H., Blomquist, G., Scott, B., Wall, A. et al. (2007). Evidence for astrocytosis in ALS demonstrated by 11C(L)-deprenyl-D2 PET. Journal of the Neurological Sciences, 255(1-2): [More information]

15 Ghaderi, A., Scott, B. (2004). The reliability and validity of the Swedish version of Body Shape Questionnaire. Scandinavian Journal of Psychology, 45(4): [More information] Ghaderi, A., Scott, B. (2003). Pure and guided self-help for full and subthreshold bulimia nervosa and binge eating disorder. British Journal of Clinical Psychology, 42: [More information] Ghaderi, A., Scott, B. (2002). The preliminary reliability and validity of the Survey for Eating Disorders (SEDs): A self-report questionnaire for diagnosing eating disorders.. European Eating Disorders Review, 10: [More information] Scott, B., Borgman, A., Johnels, B., Aquilonius, S. (2000). Gender Differences in Parkinson s disease symptom profile. Acta Neurologica Scandinavica, 102: [More information] Scott, B., Borgman, A., Engler, H., Johnels, B., Aquilonius, S. (2000). Gender differences in Parkinson's disease symptom profile. ACTA NEUROLOGICA SCANDINAVICA, 102(1): [More information] CV Lennart Pettersson Adress: Nunnevägen 1, Gustavsberg Telefon: E-post: lennartpettersson1@yahoo.se Ålder: 72 år ( 2014) Utbildning a) Fil.kand. vid Stockholms universitet 1966 (genetik, zoologi och mikrobiologi, 2 betyg av varje) b) Översiktskurs i miljövård (10 poäng) vid Lunds universitet 1970 c) Tre betyg i mikrobiologi vid Stockholms universitet 1974 d) Grundkurs i klinisk läkemedelsprövning 1991 e) Allmän patologi, 10 poäng, vid Karolinska institutet 1993 f) Diverse datakurser Anställningar

16 a) Pharmacia (medicinsk redaktör inom området infusionslösningar) b) Sockerbolaget (mikrobiologiskt utvecklingsarbete) c) Arla (mikrobiologiskt utvecklingsarbete) d) STU/NUTEK (bioteknikhandläggare med ansvar för såväl kommersiella utvecklingsprojekt som för forskningsprogram inom områden som genteknik, protein enginneeering, kolhydratkemi, peptidteknologi, bioteknisk processteknik och bioteknisk separationsteknik) e) Regeringskansliet (Jordbruksdepartementet) (handläggning av ärenden relaterade till genteknik- och genresursfrågor, deltog i internationella förhandlingar om jordbrukets växtgenetiska resurser inom ramen för FAO) Övrigt a) Har representerat STU/NUTEK i t.ex. Nordisk Industrifond, MFR:s genomgrupp, programstyrelsen för Stiftelsen Bioteknisk Forskning, EU:s grupp inom protein engineering, tekniska kommitten för COST-projekt inom agrikultur och bioteknik och SIK:s industriella råd b) Svensk representant i Nordiska Genbankens styrelse c) Spelar bordtennis, går i fjällen, åker längdskidor, läser böcker och är som folk är mest CV Bo Erixon Taxinge-Fölsjötorp, NYKÖPING Mobil , bo.erixon@parkinsonforbundet.se Bo Erixon är född Är ordförande för ParkinsonFörbundet sedan 31 maj Utbildad byggnadsingenjör, arbetar sedan 1975 som byggnadsentreprenör i ett eget familjeföretag i Nyköping. Gift och har 4 vuxna barn